tolvaptan has been researched along with Acute Disease in 55 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (14.55) | 29.6817 |
| 2010's | 37 (67.27) | 24.3611 |
| 2020's | 10 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, K; Kohno, T; Kohsaka, S; Nagatomo, Y; Shiraishi, Y; Yamazaki, Y; Yoshikawa, T | 1 |
| Amioka, N; Endo, T; Iida, T; Ito, H; Kishinoue, T; Matsuo, N; Mori, H; Nakamura, K; Nakano, Y; Onishi, N; Takaishi, A; Tanimoto, M; Ueeda, M; Yamaji, T; Yasuhara, K | 1 |
| Li, J; Yin, C; Yuan, L | 1 |
| Kawano, M; Nakano, M; Nishio, S; Tajima, E; Takimura, H; Takimura, Y; Taniguchi, R; Tsukahara, R; Tsuzuki, I; Yamaguchi, Y | 1 |
| Hasegawa, M; Hayashi, H; Inaguma, D; Koide, S; Ogata, S; Tagaya, T; Takahashi, K; Tsuboi, N; Yuzawa, Y | 1 |
| Chen, S; Du, R; Han, S; Li, J; Liu, M; Wang, L; Zhang, Q | 1 |
| Decaux, G; Gankam Kengne, F | 1 |
| Jin, Q; Luo, X; Wu, Y | 1 |
| Hu, J; Jiang, L; Li, M; Wan, Q; Yuan, F; Zhang, Y; Zhou, J | 1 |
| Fukuoka, H; Hoshida, S; Inoue, S; Inui, H; Minamisaka, T; Mine, K; Shinoda, Y; Tachibana, K; Ueda, K; Ueno, K | 1 |
| Endo, A; Kagawa, Y; Morita, Y; Ouchi, T; Sato, H; Tanabe, K; Watanabe, N; Yamaguchi, K | 1 |
| Adachi, S; Arimura, T; Fujimi, K; Iwata, A; Kitajima, K; Kuwano, T; Miura, SI; Morii, J; Morito, N; Nishikawa, H; Saku, K; Shiga, Y; Yahiro, E | 1 |
| Damman, K; Fujii, H; Fukamizu, S; Goldsmith, SR; Kagiyama, N; Kitai, T; Matsue, Y; Nishioka, T; Noda, M; Onishi, Y; Ono, Y; Satoh, Y; Sugi, K; Suzuki, M; Ter Maaten, JM; Torii, S; van der Meer, P; Voors, AA; Yamaguchi, S; Yoshida, K | 1 |
| Dobashi, S; Fujii, T; Hisatake, S; Ikeda, T; Kabuki, T; Kiuchi, S; Takashi, O | 1 |
| Cai, L; Wang, C; Xiong, B | 1 |
| Fujii, H; Fukamizu, S; Goldsmith, SR; Kagiyama, N; Kitai, T; Matsue, Y; Nishioka, T; Noda, M; Onishi, Y; Ono, Y; Satoh, Y; Sugi, K; Suzuki, M; Torii, S; Yamaguchi, S; Yoshida, K; Yoshioka, K | 1 |
| Isobe, M; Kamiyama, M; Masumura, M; Nomoto, H; Ohno, M; Oumi, T; Sakakibara, A; Satoh, Y; Sugiyama, T; Suzuki, M; Takahashi, Y; Yabe, K; Yamashita, S | 1 |
| Dobashi, S; Fujii, T; Hisatake, S; Ikeda, T; Kabuki, T; Kiuchi, S; Oka, T | 1 |
| Hamada, M; Ikeda, S; Kadota, H; Miyazaki, S; Ogimoto, A; Ohshima, K; Shimizu, H | 1 |
| Ishii, H; Izumi, K; Kamiya, H; Kawamura, Y; Murohara, T; Oguri, M; Ohguchi, S; Takahara, K; Takahashi, H; Yokoi, Y | 1 |
| Ehara, S; Kawase, Y; Matsumoto, K; Nakamura, Y; Otsuka, K | 1 |
| Matsumura, K; Morishita, S; Otagaki, M; Shiojima, I; Takagi, M; Takahashi, H; Takehana, K; Taniguchi, N; Yamamoto, Y; Yoshioka, K | 1 |
| Imamura, T; Kinugawa, K | 1 |
| Kajimoto, K; Otsubo, S | 1 |
| Fujii, H; Matsue, Y; Nagahori, W; Nishioka, T; Noda, M; Okishige, K; Onishi, Y; Ono, Y; Sakurada, H; Satoh, Y; Sugi, K; Suzuki, M; Takahashi, A; Tejima, T; Torii, S; Yamaguchi, S; Yoshida, K | 1 |
| Abe, Y; Kubota, I; Kunii, H; Nakazato, K; Ohwada, T; Saito, T; Saitoh, S; Sugimoto, K; Suzuki, H; Suzuki, S; Takeishi, Y; Yamaki, T; Yoshihisa, A | 2 |
| Formiga, F; Navarro, A; Poch, E; Pose, A; Runkle, I; Tejedor, A; Villabona, C | 1 |
| Bart, BA; Burnett, J; Goldsmith, SR | 1 |
| Formiga, F; Morales-Rull, JL; Trullàs, JC | 1 |
| Chivite, D; Corbella, X; Formiga, F | 1 |
| Fujimoto, S; Horii, M; Kawakami, R; Nakada, Y; Nakano, T; Okayama, S; Onoue, K; Saito, Y; Takeda, Y; Ueda, T; Uemura, S | 1 |
| Hashimoto, K; Ito, H; Kawai, Y; Kohno, K; Koide, Y; Miyaji, K; Miyoshi, T; Nakahama, M; Nakamura, K; Nishii, N; Tachibana, M; Terasaka, R; Toda, H; Tokioka, K; Wada, T; Watanabe, A; Yoshioka, R | 1 |
| Adams, KF; Cole, RT; Egnaczyk, GF; Felker, GM; Fiuzat, M; Gregory, D; Konstam, MA; Mentz, RJ; O'Connor, CM; Patel, CB; Udelson, JE; Wedge, P | 1 |
| Imai, R; Ishikawa, S; Iwamiya, S; Kato, T; Koyasu, M; Mitsuda, T; Miura, A; Miura, T; Murohara, T; Ozaki, Y; Shibata, R; Takemoto, K; Uchikawa, T; Uemura, Y; Watarai, M | 1 |
| Hasegawa, T; Ikeda, U; Izawa, A; Kimura, K; Misawa, T; Momose, T; Morita, T; Motoki, H | 1 |
| Fujii, H; Fukamizu, S; Goldsmith, SR; Kagiyama, N; Kitai, T; Matsue, Y; Nishioka, T; Noda, M; Onishi, Y; Ono, Y; Satoh, Y; Sugi, K; Suzuki, M; Torii, S; Yamaguchi, S; Yoshida, K | 2 |
| Hashimoto, Y; Kagiyama, N; Kume, T; Matsue, Y; Matsumura, A; Okura, H; Suzuki, M; Yoshida, K; Yoshioka, K | 1 |
| Anjaneyan, K; Doss, CR; George, M; Jena, A; Kanagesh, B; Rajaram, M; Ramaraj, B; Shanmugam, E | 1 |
| Bloomfield, DM; Cleland, JG; Cotter, G; Damman, K; Davison, B; Gheorghiade, M; Givertz, MM; Hillege, HL; Metra, M; O'Connor, CM; Ponikowski, P; Subacius, H; Teerlink, JR; Ter Maaten, JM; Valente, MA; van der Meer, P; van Veldhuisen, DJ; Voors, AA | 1 |
| Goldsmith, SR | 1 |
| Abe, M; Fukuhara, E; Fukunami, M; Furukawa, Y; Ikeda, I; Iwasaki, Y; Kawasaki, M; Kikuchi, A; Kondo, T; Morita, T; Nakamura, J; Ozaki, T; Sato, Y; Seo, M; Tamaki, S; Yamada, T | 1 |
| Ho, JE; Teerlink, JR | 1 |
| Cavalcante, JL; Gheorghiade, M; Khan, S | 1 |
| Lindenfeld, J | 1 |
| Singh, M; Slawsky, MT; Valania, G | 1 |
| Gheorghiade, M; Konstam, MA; Pang, PS | 1 |
| Hashimoto, Y; Iwatsuka, R; Matsue, Y; Matsumura, A; Mizukami, A; Nagahori, W; Ohno, M; Seya, M; Suzuki, M | 1 |
| Berl, T; Jovanovich, AJ | 1 |
| Fujiki, H; Kinoshita, S; Miyazaki, T; Mori, T; Nakamura, S; Nakayama, S; Onogawa, T; Yamamura, Y | 1 |
| Gheorghiade, M; Orlandi, C; Zimmer, CA | 1 |
| Gheorghiade, M; Mebazaa, A; Teerlink, JR | 1 |
| Batlle, D; Chen, S; Jalandhara, N | 1 |
| Yancy, CW | 1 |
15 review(s) available for tolvaptan and Acute Disease
| Article | Year |
|---|---|
Comment on: Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta-analysis.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Dyspnea; Heart Failure; Humans; Tolvaptan | 2023 |
Tolvaptan in reversing worsening acute heart failure: A systematic review and meta-analysis.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Dyspnea; Heart Failure; Humans; Prognosis; Tolvaptan | 2019 |
Hypertonic saline, isotonic saline, water restriction, long loops diuretics, urea or vaptans to treat hyponatremia.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Bicarbonates; Chronic Disease; Drinking; Humans; Hyponatremia; Practice Guidelines as Topic; Saline Solution; Saline Solution, Hypertonic; Sodium; Sodium Potassium Chloride Symporter Inhibitors; Tolvaptan; Urea; Uric Acid | 2020 |
Tolvaptan add-on therapy in patients with acute heart failure: A systematic review and meta-analysis.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heart Failure; Humans; Randomized Controlled Trials as Topic; Tolvaptan | 2020 |
Effects of Tolvaptan in patients with acute heart failure: a systematic review and meta-analysis.
Topics: Acute Disease; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Dyspnea; Female; Heart Failure; Humans; Male; Middle Aged; Odds Ratio; Randomized Controlled Trials as Topic; Recovery of Function; Sodium; Time Factors; Tolvaptan; Treatment Outcome; Weight Loss | 2017 |
Update of acute and long-term tolvaptan therapy.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Chronic Disease; Heart Failure; Humans; Japan; Time Factors; Tolvaptan | 2019 |
[Alternatives to conventional diuretic therapy in heart failure].
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardio-Renal Syndrome; Clinical Trials as Topic; Dopamine; Drug Resistance; Drug Substitution; Drug Therapy, Combination; Furosemide; Heart Failure; Hemofiltration; Humans; Multicenter Studies as Topic; Saline Solution, Hypertonic; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Tolvaptan | 2014 |
[Organ-protection therapy. A new therapeutic approach for acute heart failure?].
Topics: Acute Disease; Amides; Benzazepines; Cardio-Renal Syndrome; Dobutamine; Fumarates; Heart Failure; Humans; Hydrazones; Inflammation; Kaplan-Meier Estimate; Multicenter Studies as Topic; Natriuretic Peptide, Brain; Prognosis; Pyridazines; Randomized Controlled Trials as Topic; Recombinant Proteins; Relaxin; Simendan; Therapies, Investigational; Tolvaptan | 2014 |
Tolvaptan in Patients Hospitalized With Acute Heart Failure: Rationale and Design of the TACTICS and the SECRET of CHF Trials.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Disease Management; Heart Failure; Hospitalization; Humans; Tolvaptan | 2015 |
Role of tolvaptan in acute decompensated heart failure.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cause of Death; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure; Humans; Male; Maximum Tolerated Dose; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Survival Rate; Tolvaptan; Treatment Outcome | 2008 |
Targeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists?
Topics: Acute Disease; Animals; Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Hyponatremia; Prognosis; Pyrroles; Tolvaptan; Vasoconstriction; Vasopressins | 2011 |
Where vaptans do and do not fit in the treatment of hyponatremia.
Topics: Acute Disease; Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Chronic Disease; Drug Costs; Hormone Antagonists; Humans; Hyponatremia; Receptors, Vasopressin; Sodium; Tolvaptan; Treatment Outcome | 2013 |
Role of vasopressin antagonists in the management of acute decompensated heart failure.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Pyrroles; Stroke Volume; Tolvaptan; Treatment Outcome; Vasoconstriction; Vasopressins | 2005 |
Pharmacology of new agents for acute heart failure syndromes.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiotonic Agents; Clinical Trials as Topic; Endothelin Receptor Antagonists; Heart Failure; Humans; Hydrazones; Pyridazines; Pyridines; Simendan; Syndrome; Tetrazoles; Tolvaptan; Vasodilator Agents | 2005 |
Evaluation and management of hyponatremia: an emerging role for vasopressin receptor antagonists.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hyponatremia; Male; Prognosis; Receptors, Vasopressin; Risk Assessment; Severity of Illness Index; Tolvaptan; Treatment Outcome; Water-Electrolyte Imbalance | 2007 |
16 trial(s) available for tolvaptan and Acute Disease
| Article | Year |
|---|---|
Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; China; Female; Fluid Shifts; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Sodium Potassium Chloride Symporter Inhibitors; Time Factors; Tolvaptan; Torsemide; Treatment Outcome; Ultrafiltration; Urination; Weight Loss | 2020 |
Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction.
Topics: Acute Disease; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuresis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glomerular Filtration Rate; Heart Failure; Humans; Hyponatremia; Injections, Intravenous; Male; Renal Insufficiency; Retrospective Studies; Time Factors; Tolvaptan; Treatment Outcome | 2017 |
Prognostic importance of sodium level trajectory in acute heart failure.
Topics: Acute Disease; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Cause of Death; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Hospital Mortality; Humans; Hyponatremia; Japan; Male; Prognosis; Retrospective Studies; Sodium; Survival Rate; Time Factors; Tolvaptan | 2017 |
Mechanisms of Diuresis for Acute Decompensated Heart Failure by Tolvaptan.
Topics: Acute Disease; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Creatinine; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Electric Impedance; Female; Follow-Up Studies; Heart Failure; Humans; Hyponatremia; Male; Middle Aged; Prognosis; Renal Insufficiency; Retrospective Studies; Tolvaptan | 2017 |
Comparison of two dosing methods for immediate administration of tolvaptan in acute decompensated heart failure.
Topics: Acute Disease; Aged; Antidiuretic Hormone Receptor Antagonists; Drug Administration Schedule; Female; Heart Failure; Hospitalization; Humans; Male; Time Factors; Tolvaptan; Treatment Outcome | 2018 |
Clinical effectiveness of tolvaptan in patients with acute decompensated heart failure and renal failure: design and rationale of the AQUAMARINE study.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Drug Therapy, Combination; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Japan; Natriuretic Peptide, Brain; Prospective Studies; Renal Insufficiency; Research Design; Tolvaptan | 2014 |
Acute heart failure volume control multicenter randomized (AVCMA) trial: comparison of tolvaptan and carperitide.
Topics: Acute Disease; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Atrial Natriuretic Factor; Benzazepines; Diuretics; Female; Heart Failure; Humans; Male; Middle Aged; Tolvaptan | 2013 |
Long-term effects and prognosis in acute heart failure treated with tolvaptan: the AVCMA trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Benzazepines; Creatinine; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Tolvaptan | 2014 |
Echocardiographic characteristics of patients with acute heart failure requiring tolvaptan: a retrospective study.
Topics: Acute Disease; Aged; Benzazepines; Diuretics; Echocardiography; Female; Heart Failure; Humans; Male; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tolvaptan; Treatment Outcome; Ventricular Dysfunction, Left | 2015 |
Early administration of tolvaptan preserves renal function in elderly patients with acute decompensated heart failure.
Topics: Acute Disease; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Hospitalization; Humans; Male; Renal Insufficiency; Tolvaptan | 2016 |
Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction.
Topics: Acute Disease; Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuresis; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Heart Failure; Humans; Male; Prospective Studies; Renal Insufficiency; Tolvaptan; Treatment Outcome | 2016 |
Effect of tolvaptan on acute heart failure with hyponatremia--a randomized, double blind, controlled clinical trial.
Topics: Acute Disease; Administration, Oral; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Hyponatremia; Male; Middle Aged; Sodium; Tolvaptan; Treatment Outcome | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diuresis; Diuretics; Female; Furosemide; Heart Failure; Hemoglobins; Humans; Kaplan-Meier Estimate; Kidney; Male; Middle Aged; Patient Readmission; Predictive Value of Tests; Reproducibility of Results; Risk Assessment; Risk Factors; Time Factors; Tolvaptan; Treatment Outcome; Xanthines | 2016 |
Prognostic impact of early treatment with tolvaptan in patients with acute heart failure and renal dysfunction.
Topics: Acute Disease; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Comorbidity; Early Medical Intervention; Female; Glomerular Filtration Rate; Heart Failure; Hospitalization; Humans; Kidney Function Tests; Male; Middle Aged; Prognosis; Renal Insufficiency; Tolvaptan; Treatment Outcome | 2016 |
Tolvaptan Reduces the Risk of Worsening Renal Function in Patients With Acute Decompensated Heart Failure and Preserved Left Ventricular Ejection Fraction - Prospective Randomized Controlled Study.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Creatinine; Diuretics; Female; Heart Failure; Humans; Kidney Diseases; Male; Middle Aged; Stroke Volume; Tolvaptan; Urea; Ventricular Function, Left; Young Adult | 2017 |
Pharmacotherapy of acute and chronic heart failure: part 2.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Heart Failure; Humans; Male; Prognosis; Prospective Studies; Risk Assessment; Severity of Illness Index; Survival Rate; Tolvaptan; Treatment Outcome | 2009 |
24 other study(ies) available for tolvaptan and Acute Disease
| Article | Year |
|---|---|
Temporal trends in tolvaptan use after revision of national heart failure guidelines in Japan.
Topics: Acute Disease; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Female; Heart Failure; Hospital Mortality; Humans; Japan; Male; Prospective Studies; Risk Factors; Tolvaptan | 2021 |
Innovative clinical pathway shortened the length of hospital stay and prevented readmission in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Critical Pathways; Heart Failure; Humans; Length of Stay; Patient Readmission; Tolvaptan | 2022 |
Impact of the time-to-target rate of urine volume concept on the outcome of acute decompensated heart failure.
Topics: Acute Disease; Diuretics; Heart Failure; Hospital Mortality; Humans; Natriuretic Peptide, Brain; Retrospective Studies; Tolvaptan | 2023 |
Tolvaptan's Association with Low Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease and Acute Decompensated Heart Failure.
Topics: Acute Disease; Acute Kidney Injury; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Furosemide; Heart Failure; Humans; Male; Renal Insufficiency, Chronic; Retrospective Studies; Tolvaptan | 2023 |
Tolvaptan-induced hypernatremia related to low serum potassium level accompanying high blood pressure in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Biomarkers; Blood Pressure; Female; Heart Failure; Hospitalization; Humans; Hypernatremia; Male; Potassium; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Tolvaptan; Treatment Outcome | 2020 |
Clinical effectiveness and adverse events associated with tolvaptan in patients above 90 years of age with acute decompensated heart failure.
Topics: Acute Disease; Age Factors; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Female; Follow-Up Studies; Heart Failure; Humans; Male; Retrospective Studies; Stroke Volume; Tolvaptan; Treatment Outcome | 2021 |
Effects of Tolvaptan With or Without the Pre-Administration of Renin-Angiotensin System Blockers in Hospitalized Patients With Acute Decompensated Heart Failure.
Topics: Acute Disease; Aged; Angiotensin-Converting Enzyme Inhibitors; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Retrospective Studies; Tolvaptan; Treatment Outcome; Urination | 2017 |
Experience with long-term administration of tolvaptan to patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Echocardiography; Female; Heart Failure; Hospital Mortality; Hospitalization; Humans; Male; Middle Aged; Mortality; Patient Readmission; Retrospective Studies; Time Factors; Tolvaptan | 2017 |
The relationship between the time until commencement of tolvaptan and the length of hospital stay in heart failure patients.
Topics: Acute Disease; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Echocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Length of Stay; Male; Retrospective Studies; Tolvaptan; Treatment Outcome | 2018 |
Impact of chronic kidney disease on the diuretic response of tolvaptan in acute decompensated heart failure.
Topics: Acute Disease; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Disease Progression; Diuresis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glomerular Filtration Rate; Heart Failure; Humans; Male; Renal Insufficiency, Chronic; Retrospective Studies; Tolvaptan; Treatment Outcome | 2017 |
The effects of tolvaptan dose on cardiac mortality in patients with acute decompensated heart failure after hospital discharge.
Topics: Acute Disease; Administration, Oral; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cause of Death; Dose-Response Relationship, Drug; Echocardiography; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Japan; Male; Patient Discharge; Patient Readmission; Prognosis; Retrospective Studies; Stroke Volume; Survival Rate; Tolvaptan | 2018 |
Prognostic factors for long-term outcomes in acute decompensated heart failure patients under tolvaptan treatment.
Topics: Acute Disease; Aged; Antidiuretic Hormone Receptor Antagonists; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Humans; Japan; Male; Patient Readmission; Prognosis; Sodium; Stroke Volume; Survival Rate; Time Factors; Tolvaptan | 2019 |
Adding High-Dose Spironolactone to Tolvaptan Improves Acute Decompensated Heart Failure Due to Obstructive Hypertrophic Cardiomyopathy and Aortic Stenosis: A Case Report.
Topics: Acute Disease; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Aortic Valve Stenosis; Cardiomyopathy, Hypertrophic; Drug Therapy, Combination; Dyspnea; Female; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Spironolactone; Tolvaptan | 2019 |
[The treament of hyponatremia secundary to the syndrome of inappropriate antidiuretic hormone secretion].
Topics: Acute Disease; Algorithms; Benzazepines; Combined Modality Therapy; Decision Support Techniques; Fluid Therapy; Furosemide; Humans; Hyponatremia; Inappropriate ADH Syndrome; Infusions, Intravenous; Saline Solution, Hypertonic; Severity of Illness Index; Tolvaptan | 2013 |
Decongestive therapy and renal function in acute heart failure: time for a new approach?
Topics: Acute Disease; Benzazepines; Dopamine; Heart Failure; Humans; Kidney; Natriuretic Peptide, Brain; Tolvaptan; Ultrafiltration | 2014 |
Clinical characteristics of responders to treatment with tolvaptan in patients with acute decompensated heart failure: Importance of preserved kidney size.
Topics: Acute Disease; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Glomerular Filtration Rate; Heart Failure; Humans; Japan; Kidney; Male; Middle Aged; Multivariate Analysis; Organ Size; Osmolar Concentration; Prospective Studies; Tolvaptan | 2016 |
Clinical benefit of tolvaptan in patients with acute decompensated heart failure and chronic kidney disease.
Topics: Acute Disease; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Creatinine; Female; Follow-Up Studies; Glomerular Filtration Rate; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Patient Readmission; Renal Insufficiency, Chronic; Retrospective Studies; Tolvaptan | 2016 |
Recovery from hyponatremia in acute phase is associated with better in-hospital mortality rate in acute heart failure syndrome.
Topics: Acute Disease; Age Factors; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Heart Failure; Hospital Mortality; Humans; Hyponatremia; Male; Myocardial Ischemia; Prognosis; Retrospective Studies; Sex Factors; Tolvaptan | 2016 |
Future Study With Tolvaptan in Acute Heart Failure.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Heart Failure; Humans; Tolvaptan | 2017 |
EVEREST study: Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan.
Topics: Acute Disease; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiovascular Agents; Europe; Female; Heart Failure; Hospitalization; Humans; Hyponatremia; Male; Middle Aged; North America; Randomized Controlled Trials as Topic; Tolvaptan | 2008 |
Seeking new heights in acute heart failure syndromes: lessons from ASCEND and EVEREST.
Topics: Acute Disease; Benzazepines; Drug Approval; Heart Failure; Humans; Natriuretic Peptide, Brain; Randomized Controlled Trials as Topic; Syndrome; Tolvaptan; Treatment Outcome; Vasodilator Agents | 2013 |
Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Comparative Effectiveness Research; Creatinine; Diuresis; Diuretics; Female; Furosemide; Heart Failure; Humans; Hypernatremia; Kidney Function Tests; Male; Multivariate Analysis; Natriuretic Peptide, Brain; Prospective Studies; Renal Insufficiency; Time Factors; Tolvaptan; Urination | 2013 |
Therapeutic effects of tolvaptan, a potent, selective nonpeptide vasopressin V2 receptor antagonist, in rats with acute and chronic severe hyponatremia.
Topics: Acute Disease; Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Water; Brain; Chronic Disease; Diuresis; Hyponatremia; Male; Organ Size; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Sodium; Tolvaptan; Urine | 2005 |
Climbing the mountain of acute decompensated heart failure: the EVEREST Trials.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiovascular Agents; Heart Failure; Humans; Tolvaptan | 2007 |